CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer

Published:2016-01-15 Issue:1 Volume:48 Page:142-152
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Go Se-Il,Ko Gyung Hyuck,Lee Won Sup,Kim Rock Bum,Lee Jeong-Hee,Jeong Sang-Ho,Lee Young-Joon,Hong Soon Chan,Ha Woo Song

Funder

Ministry for Health, Welfare and Family Affairs, Republic of Korea

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2014-227.pdf

Reference17 articles.

1. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011

2. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

3. CD44 is the principal cell surface receptor for hyaluronate

4. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins [published erratum appears in J Cell Biol 1991 Feb;112(3):following 513]

5. CD44H regulates tumor cell migration on hyaluronate-coated substrate.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic and prognostic value of CD44v9 and TIM3 expression in CK^‑ and CK⁺ regions in gastric cancer tissues;Oncology Letters;2024-08-06

2. Can Nano Yield Big Insights? Oligonucleotide-Based Biosensors in Early Diagnosis of Gastric Cancer;Chemosensors;2024-03-06

3. Single-cell RNA-seq reveals MIF−(CD74 + CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma;Oral Oncology;2024-01

4. The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer;International Journal of Molecular Sciences;2023-10-31

5. Late recurrent gastric carcinoma 12 years after surgery with attenuation of CD44 variant 9 expression;Surgical Case Reports;2023-05-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3